You are here

Structural & Congenital Heart Disease

 

Patients who received a mechanical prosthesis for surgical replacement of aortic or mitral valves derived a significant long-term survival benefit versus those who received a biologic prosthesis, according to a study in the New England Journal of Medicine.

Nearly half of all valve hospitals in the U.S. are misclassified as either low- or high-performing, according to research published in JAMA Cardiology—but that problem might have a simple fix.

DENVER — Transcatheter aortic valve replacement (TAVR) is an “economically dominant” strategy compared to surgical aortic valve replacement (SAVR) for patients with aortic stenosis at intermediate surgical risk, according to data presented by David J. Cohen, MD, MSc, Oct. 31 at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Research examining 278 patients with in-stent restenosis (ISR) found that drug-eluting balloon (DEB) was non-inferior in comparison with drug-eluting stent (DES) in terms of six-month minimal lumen diameter (MLD).

DENVER — Measuring frailty could lead to more accurate predictions of outcomes following transcatheter aortic valve replacement (TAVR) than a validated risk algorithm, according to research presented Oct. 30 at the annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

 

Recent Headlines

Researchers clarify how zinc levels effect cardiac function

A new study by researchers at the Technical University of Munich in Germany clarifies the relationship between levels of zinc and its effect on cardiac function.

Pregnant women with congenital heart disease may have higher risk of poor outcomes during delivery

Pregnant women with congenital heart disease (CHD) had an increased risk of congestive heart failure, atrial arrhythmias and fetal growth restrictions during delivery, according to a retrospective database analysis.

78% of cardiothoracic surgeons perform TAVR procedures as part of team

More than three-quarters of cardiothoracic surgeons performed transcatheter aortic valve replacement (TAVR) procedures as part of a heart team, according to a Society of Thoracic Surgeons (STS) survey.

Intel co-founder, wife donate $50 million for children’s hospital at Stanford

Gordon and Betty Moore donated $50 million to the Lucille Packard Children’s Hospital Stanford in Palo Alto, California, the largest private gift the hospital received since David and Lucille Packard’s donation to found the hospital.

Boston Scientific acquires privately held TAVR company for $435 million

Boston Scientific agreed to acquire Symetis SA on March 30 for $435 million in an all-cash deal.

ACC.17: Subclinical leaflet thrombosis occurs more often in TAVR versus SAVR patients

Subclinical leaflet thrombosis occurred in 13.6 percent of patients undergoing transcatheter aortic valve replacement (TAVR) and 3.8 percent of patients undergoing surgical aortic valve replacement (SAVR), according to an analysis of two registries.

FDA approves the CoreValve Evolut PRO TAVR valve for high or extreme risk patients

The FDA approved the CoreValve Evolut PRO valve for transcatheter aortic valve replacement (TAVR) in patients with severe, symptomatic aortic stenosis who are at high or extreme risk for open heart surgery.

ACC.17: SURTAVI trial finds TAVR, SAVR have similar all-cause mortality rates at 24 months

After two years, intermediate-risk patients with severe symptomatic aortic stenosis had similar rates of all-cause mortality or disabling stroke whether they underwent transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR), according to a randomized trial.

FDA expands approval of the Melody transcatheter pulmonary valve

The FDA approved the Melody transcatheter pulmonary valve for patients whose surgical bioprosthetic pulmonary heart valves failed.

Mayo Clinic, Children’s Hospital of Philadelphia collaborate on congenital heart disease program

The Mayo Clinic and the Children’s Hospital of Philadelphia are working together to delay and prevent heart failure from hypoplastic left heart syndrome (HLHS), a rare and complex form of congenital heart disease in children.

Pages